On April 29, the Guangzhou Nansha New Area Conference on Promoting the High-quality Development of the Biomedical Industry was held in Nansha. Relevant persons in charge of biomedical enterprises, scientific research institutions, medical institutions, industrial parks, service organizations and other relevant persons in charge and experts and scholars gathered together to discuss the high-quality development of Nansha's biomedical industry.
At the meeting, the People's Government of Nansha District issued the "Opinions on Accelerating the High-quality Development of the Biomedical Industry in Nansha, Guangzhou" and the "Measures for Supporting the High-quality Development of the Biomedical Industry in Nansha, Guangzhou".
Meng Hao, Deputy Secretary-General of the Guangzhou Municipal Government, Wang Junfeng, Chief Engineer of the Cyber Security Industry Development Center of the Ministry of Industry and Information Technology, Wu Yang, Deputy Secretary of the Nansha District Party Committee and District Mayor, delivered a speech, Li Xuezhi, Deputy Secretary of the Party Committee of the Guangzhou Laboratory, Li Deqiu, Director of the Standing Committee of the Nansha District People's Congress, and Weng Shuwu, Chairman of the Nansha District CPPCC, attended the event, and Xie Wei, Deputy Secretary of the Party Working Committee of Nansha Development Zone, presided over the event.
A number of advantageous policies have been increased
Strive to build an international medical and health highland
Wu Yang said in his speech that at present, biomedicine has become an important "battlefield" for a new round of global scientific and technological revolution and industrial transformation, and is the main direction of strategic emerging industries in the mainland. In recent years, Nansha has taken the biomedical industry as the key direction of cultivating new quality productivity, and its policy advantages have been continuously strengthened, its industrial strength has been continuously enhanced, and innovative resources have been continuously gathered.
In the future, Nansha will focus on the following aspects to expand and strengthen the biomedical industry:
- The first is to carry out the promotion of space carriers. It is planned to build the Pearl River Innovation Valley, the Biological Valley and the Health Valley, accelerate the construction of an international medical and health city, and encourage and support the Guangdong Medical Valley, the International Medicine Valley of Sun Yat-sen University, the Nansha Fudan International Science and Technology Innovation Park, the Hengli Biomedical Industrial Park of the Science and Technology Innovation Center, and the Life and Health Industrial Park of the Science and Technology Innovation Center to improve their energy level.
- The second is to carry out the reengineering of the industrial base. Based on its own foundation, Nansha will build a whole industrial ecology around the advantageous fields of drugs, medical devices, medical services, etc., and create a "4+2+2" characteristic industrial system.
- The third is to carry out the action of cultivating and nurturing strong enterprises. We will do a good job in providing excellent and refined enterprise services, thoroughly implement the enterprise gradient cultivation plan, and continue to do a good job in attracting investment.
- The fourth is to carry out industrial ecological construction actions. We will continue to make efforts in talent incentives, financial empowerment, transformation of scientific and technological achievements, and policy support, so as to build Nansha into a new highland for biomedical innovation and industrial development in the Greater Bay Area.
△Nansha Hengli Biomedical Industrial Park
Jin Li, academician of the Chinese Academy of Sciences, president of Fudan University, and president of the Guangdong-Hong Kong-Macao Greater Bay Area Institute of Precision Medicine (Guangzhou), said in his report that the development of the precision medicine industry requires overall planning and policy design, gathering clinical, research and industrialization forces, and creating an industrial ecosystem that runs through the entire industry chain to form a virtuous circle.
In terms of the concept of building a pilot demonstration zone for the precision medicine industry, he pointed out that Nansha should be the central hub, cooperate with Hong Kong and Macao, and build a global network of integrated innovation centers at home and abroad.
Cultivate "unicorns" and "ballast stones" in the fields of precision prevention and treatment of major diseases and rare diseases, original innovative drugs, high-end medical devices, and precision health management, build leading science and technology enterprises, build a precision medicine industry ecology with "small projects overwhelming, and large projects stand tall in the sky", and accelerate the cultivation and construction of life and health industry clusters.
Wei Min, member of the Standing Committee of the Nansha District Party Committee and executive deputy head of the district, introduced the "Opinions on Accelerating the High-quality Development of the Biomedical Industry in Nansha, Guangzhou" from four aspects: development goals, key tracks, spatial layout, and landing measures.
He said that Nansha will firmly grasp the reform pilot tasks and provincial and municipal support policies entrusted by the state, adhere to the equal emphasis on R&D, manufacturing and service, focus on drugs, medical devices, medical services and other fields, and strive to build a policy support system for the whole biomedical industry chain covering R&D, clinical, manufacturing, elements and ecology.
By 2026, Nansha will have more than 1,000 biomedical enterprises and an industrial scale of more than 50 billion yuan, and strive to build an influential international medical service highland.
The event also officially released the "Guangzhou Nansha Support Measures for Promoting the High-quality Development of the Biomedical Industry" (hereinafter referred to as the "Nine Biomedicine Measures") to support the development of Nansha biomedical enterprises in leading enterprises, clinical trials, scene applications, etc., of which up to 100 million yuan will be rewarded and supported for leading enterprises.
Wei Min introduced that the "Nine Articles of Biomedicine" was issued by the national, provincial and municipal governments after the "Overall Plan for Deepening the Comprehensive Cooperation between Guangdong, Hong Kong and Macao in Nansha, Guangzhou", "Opinions on Supporting Guangzhou Nansha to Relax Market Access and Strengthen the Reform of the Regulatory System", "Regulations on Deepening the Comprehensive Cooperation between Guangdong, Hong Kong and Macao in Nansha Facing the World" and other series of documents.
It is understood that in recent years,
Nansha District continues to promote cross-border medical integration,
In addition to constantly expanding
"Hong Kong and Macao Medicines and Medical Devices Connect" catalogue,
In the promotion of elderly health care vouchers
implementation and other aspects
It has also ushered in new progress.
Swipe up and down to see details
At present, the "Hong Kong and Macao Medicines and Medical Devices Connect" has been officially implemented in Nansha, which can promote the interconnection of medical resources between Guangzhou and Hong Kong, so that residents in the Greater Bay Area can enjoy high-quality services that are homogeneous with Hong Kong and in line with international standards without leaving the district.
In February this year, the Hong Kong Special Administrative Region Government announced the "Elderly Health Care Voucher Greater Bay Area Pilot Scheme", in which the First Affiliated Hospital of Sun Yat-sen University (Nansha) was selected as the first batch of pilot lists, and it is expected to be able to provide services in the second half of this year.
In addition to the Medical Device Pass, the Hong Kong and Macao Residents Health Service Centre is another example of medical connectivity in the Greater Bay Area. Relying on the Nansha Hospital of Guangzhou First People's Hospital - Health Service Center for Hong Kong and Macao Residents and the Hong Kong-style Gold Medal General Outpatient Department, Nansha provides residents in the jurisdiction with one-stop medical services such as remote consultation, cross-border referral, Internet diagnosis and treatment, and direct payment of insurance claims.
Up to now, the Nansha Hospital of Guangzhou First People's Hospital - Health Service Center for Hong Kong and Macao Residents and the Hong Kong-style Gold Medal General Outpatient Department have provided more than 5,100 medical services to residents in the Greater Bay Area, including more than 800 medical services for people from overseas, Hong Kong and Macao.
The government, medical institutions, and enterprises work together
Promote the transfer and transformation of biomedical technology
At the conference, Guangdong Medical Valley, the First Affiliated Hospital of Sun Yat-sen University, the First People's Hospital of Guangzhou, the Market Supervision Bureau of Nansha District, the Guangdong Medical Device Standardization Technical Committee, the Guangdong Medical Device Industry Association, Guangzhou Pharmaceutical Economic News Publishing Co., Ltd., Yueke Port and Shipping Financial Leasing Co., Ltd., Zhongda International Medicine Valley, Guangdong-Hong Kong-Macao Greater Bay Area Precision Medicine Research Institute (Guangzhou), Guangzhou Women and Children's Medical Center, Guangzhou Xingyong Enterprise Management Service Co., Ltd., Guangzhou Pharmaceutical Association and other biomedical institutions, government departments, The company signed strategic cooperation agreements to jointly promote the transfer and industrialization of biomedical technology achievements in Nansha, further promote the deep integration of the industrial chain and innovation chain, and serve the high-quality development of the economy and society.
"As the core hub of the Guangdong-Hong Kong-Macao Greater Bay Area, Nansha has unique geographical and policy advantages, and has a solid foundation for the development of the biomedical industry. ”
Yin Xiaoyu, vice president of the First Affiliated Hospital of Sun Yat-sen University, said in an interview that he looks forward to taking this conference as an opportunity to further expand the "circle of friends" in the core field of biomedicine, jointly explore a new cooperation model between the hospital and the development of the biomedical industry, and make concerted efforts in the fields of scientific research projects and joint construction of clinical research platforms, so as to break through the blockages and difficulties in key links such as clinical research, achievement transformation and clinical application, and jointly promote the transformation and upgrading of the biomedical industry and cultivate and expand the new quality productivity of biomedicine. Contribute to the construction of Nansha District and the biomedical highland in the Greater Bay Area.
In recent years, Nansha has gathered more than 400 biomedical enterprises, involving immune cell therapy, stem cell and regenerative medicine, innovative drugs, precision medicine, high-end medical devices and other fields.
It has cultivated platform projects such as Guangdong Medical Valley, a national science and technology business incubator, and the Guangdong-Hong Kong-Macao Greater Bay Area Precision Medicine Research Institute (Guangzhou), and laid out and built six tertiary hospitals, including the First Affiliated (Nansha) Hospital of Sun Yat-sen University, and continuously consolidated the foundation for the development of the biomedical industry.
△The First Affiliated (Nansha) Hospital of Sun Yat-sen University
Nansha District, together with the First Affiliated Hospital of Sun Yat-sen University and the First People's Hospital of Guangzhou, will build Nansha into a leader in medical treatment, biomedicine and health in the Guangdong-Hong Kong-Macao Greater Bay Area, jointly explore the establishment of an industry-university-research cooperation platform, explore the clinical application of restricted cell transplantation treatment technology, research the service guarantee and innovation and entrepreneurship mechanism of the transformation of the whole process of results, and cultivate a brand with international influence in cutting-edge fields such as precision medicine, innovative drugs, implantable and interventional medical devices, and cell and gene therapy.
"The future of cell therapy looks at China, and China's cell therapy looks at Nansha!" Xie Jiasheng, CEO of Guangdong Medical Valley, said in an interview that the development of Nansha's biomedical industry has a good policy environment and soil, and the continuous increase of these innovative policies is an important guarantee for the accelerated development of the biomedical industry in Nansha District.
The 9th "Maker China" Biomedicine
The SME Innovation and Entrepreneurship Competition was launched
At the end of the event, the 9th "Maker China" Biomedical SME Innovation and Entrepreneurship Competition was officially launched.
At the launching ceremony of the competition, representatives of the organizing committee of the competition gave a detailed introduction to the 9th "Maker China" Biomedical SME Innovation and Entrepreneurship Competition.
According to reports,
"Maker China" is the State Council
Implement the innovation-driven development strategy,
Promote the development of large, medium and small enterprises,
Encourage innovation and entrepreneurship to be launched
public service platform,
The tournament has been successfully held for eight times.
The 9th "Maker China" Biomedical SME Innovation and Entrepreneurship Competition is an important measure and public welfare activity led by the government, social cohesion, and enterprise agglomeration to help the sustainable and high-quality development of the biomedical industry.
The competition focuses on the development needs and problems of the biomedical industry, stimulates innovation vitality and development potential, helps the transformation and application of outstanding innovation achievements, incubates a number of biomedical innovation and entrepreneurship projects, cultivates a number of potential biomedical hidden champion enterprises, and promotes the sustainable and steady development of the biomedical industry.
It is reported that the competition is open to small and medium-sized enterprises, maker teams, scientific research institutions, etc., and recruits biomedical innovation and entrepreneurship projects, including but not limited to small and medium-sized enterprises and entrepreneurial projects in the biomedical industry, biomedical engineering industry, biological agriculture and related industries, biomass energy industry, other biological industries, health care and other industries.
The competition is divided into four stages: project registration, preliminary competition, qualifier and final, and each stage of the event is held online or offline according to the actual situation, and the final venue is in Nansha District, Guangzhou.
Xiao Nan will show you
"May Day" tour in Nansha丨 Please check the → for the integrated strategy of eating and living
Interview with Nansha Famous School | Revealing the "acceleration" behind the high "processing value" of Nansha Huafu
Correspondents: District Development and Reform Bureau, District Science and Technology Bureau, District Industry and Information Technology Bureau, District Health Bureau
Text: Liu Chao
Photos: Organizers, Liu Wei, Luo Zhongxian
Editor: Wu Jiaojiao
Proofreading: Liang Sijing
First instance: Li Xiatong
Second trial: Huang Zengcai
Final review: Ye Pingsheng
Producer: Nansha District Rong Media Center
Submission email: [email protected] (This article was originally published by "Guangzhou Nansha Release", without authorization, any media and public account shall not be reproduced and adapted, welcome to share it with friends.) ）